Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repertaxin for Prevention of Primary Graft Dysfunction After Lung Transplantation
NCT00224406Phase 2Completed
- Sponsor
- Dompé
- Start
- May 2005
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of reparixin in primary graft dysfunction (PGD), sponsored by Dompé. Started May 2005; status: completed.
02
Drugs
reparixin
03
Conditions
primary graft dysfunction (PGD)
Beyond the preview
Go deeper on NCT00224406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00224406.